Exploring the common pathogenesis of Alzheimer's disease and type 2 diabetes mellitus via microarray data analysis

被引:8
作者
Ye, Xian-wen [1 ,2 ,3 ]
Liu, Meng-nan [1 ,3 ]
Wang, Xuan [3 ]
Cheng, Shui-qing [3 ]
Li, Chun-shuai [3 ]
Bai, Yu-ying [3 ]
Yang, Lin-lin [3 ]
Wang, Xu-xing [3 ]
Wen, Jia [3 ]
Xu, Wen-juan [3 ]
Zhang, Shu-yan [3 ]
Xu, Xin-fang [1 ,2 ,3 ]
Li, Xiang-ri [1 ,2 ,3 ]
机构
[1] Beijing Univ Chinese Med, Ctr TCM Proc Res, Beijing, Peoples R China
[2] Beijing Univ Chinese Med, Beijing Key Lab Qual Evaluat Chinese Mat Med, Beijing, Peoples R China
[3] Beijing Univ Chinese Med, Sch Tradit Chinese Med, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
network pharmacology; Alzheimer's disease; type 2 diabetes mellitus; bioinformatics analysis; pathophysiological mechanisms; SUSCEPTIBILITY; METAANALYSIS; MECHANISMS; DEMENTIA; RISK;
D O I
10.3389/fnagi.2023.1071391
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
BackgroundAlzheimer's Disease (AD) and Type 2 Diabetes Mellitus (DM) have an increased incidence in modern society. Although more and more evidence has supported that DM is prone to AD, the interrelational mechanisms remain fully elucidated. PurposeThe primary purpose of this study is to explore the shared pathophysiological mechanisms of AD and DM. MethodsDownload the expression matrix of AD and DM from the Gene Expression Omnibus (GEO) database with sequence numbers GSE97760 and GSE95849, respectively. The common differentially expressed genes (DEGs) were identified by limma package analysis. Then we analyzed the six kinds of module analysis: gene functional annotation, protein-protein interaction (PPI) network, potential drug screening, immune cell infiltration, hub genes identification and validation, and prediction of transcription factors (TFs). ResultsThe subsequent analyses included 339 common DEGs, and the importance of immunity, hormone, cytokines, neurotransmitters, and insulin in these diseases was underscored by functional analysis. In addition, serotonergic synapse, ovarian steroidogenesis, estrogen signaling pathway, and regulation of lipolysis are closely related to both. DEGs were input into the CMap database to screen small molecule compounds with the potential to reverse AD and DM pathological functions. L-690488, exemestane, and BMS-345541 ranked top three among the screened small molecule compounds. Finally, 10 essential hub genes were identified using cytoHubba, including PTGS2, RAB10, LRRK2, SOS1, EEA1, NF1, RAB14, ADCY5, RAPGEF3, and PRKACG. For the characteristic A beta and Tau pathology of AD, RAPGEF3 was associated significantly positively with AD and NF1 significantly negatively with AD. In addition, we also found ADCY5 and NF1 significant correlations with DM phenotypes. Other datasets verified that NF1, RAB14, ADCY5, and RAPGEF3 could be used as key markers of DM complicated with AD. Meanwhile, the immune cell infiltration score reflects the different cellular immune microenvironments of the two diseases. ConclusionThe common pathogenesis of AD and DM was revealed in our research. These common pathways and hub genes directions for further exploration of the pathogenesis or treatment of these two diseases.
引用
收藏
页数:16
相关论文
共 53 条
[1]   Altered gene expression profiles in the hippocampus and prefrontal cortex of type 2 diabetic rats [J].
Abdul-Rahman, Omar ;
Sasvari-Szekely, Maria ;
Ver, Agota ;
Rosta, Klara ;
Szasz, Bernadett K. ;
Kereszturi, Eva ;
Keszler, Gergely .
BMC GENOMICS, 2012, 13
[2]   Disentangling the biological pathways involved in early features of Alzheimer's disease in the Rotterdam Study [J].
Ahmad, Shahzad ;
Bannister, Christian ;
van der Lee, Sven J. ;
Vojinovic, Dina ;
Adams, Hieab H. H. ;
Ramirez, Alfredo ;
Escott-Price, Valentina ;
Sims, Rebecca ;
Baker, Emily ;
Williams, Julie ;
Holmans, Peter ;
Vernooij, Meike W. ;
Ikram, M. Arfan ;
Amin, Najaf ;
van Duijn, Cornelia M. .
ALZHEIMERS & DEMENTIA, 2018, 14 (07) :848-857
[3]   Lysosomal Network Proteins as Potential Novel CSF Biomarkers for Alzheimer's Disease [J].
Armstrong, Andrea ;
Mattsson, Niklas ;
Appelqvist, Hanna ;
Janefjord, Camilla ;
Sandin, Linnea ;
Agholme, Lotta ;
Olsson, Bob ;
Svensson, Samuel ;
Blennow, Kaj ;
Zetterberg, Henrik ;
Kagedal, Katarina .
NEUROMOLECULAR MEDICINE, 2014, 16 (01) :150-160
[4]   Diabetes and Alzheimer's disease crosstalk [J].
Baglietto-Vargas, David ;
Shi, Jessica ;
Yaeger, Devin M. ;
Ager, Rahasson ;
LaFerla, Frank M. .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2016, 64 :272-287
[5]   Diabetes drugs in the fight against Alzheimer's disease [J].
Boccardi, Virginia ;
Murasecco, Ilenia ;
Mecocci, Patrizia .
AGEING RESEARCH REVIEWS, 2019, 54
[6]   Insulin Resistance and Diabetes Mellitus in Alzheimer's Disease [J].
Burillo, Jesus ;
Marques, Patricia ;
Jimenez, Beatriz ;
Gonzalez-Blanco, Carlos ;
Benito, Manuel ;
Guillen, Carlos .
CELLS, 2021, 10 (05)
[7]  
Chen Q, 2021, AM J TRANSL RES, V13, P11316
[8]   SOS1 gene polymorphisms are associated with gestational diabetes mellitus in a Chinese population: Results from a nested case-control study in Taiyuan, China [J].
Chen, Qiong ;
Yang, Hailan ;
Feng, Yongliang ;
Zhang, Ping ;
Wu, Weiwei ;
Li, Shuzhen ;
Thompson, Brian ;
Wang, Xin ;
Peng, Tingting ;
Wang, Fang ;
Xie, Bingjie ;
Guo, Pengge ;
Li, Mei ;
Wang, Ying ;
Zhao, Nan ;
Wang, Suping ;
Zhang, Yawei .
DIABETES & VASCULAR DISEASE RESEARCH, 2018, 15 (02) :158-161
[9]   Amyloid precursor protein (APP) traffics from the cell surface via endosomes for amyloid β (Aβ) production in the trans-Golgi network [J].
Choy, Regina Wai-Yan ;
Cheng, Zhiliang ;
Schekman, Randy .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (30) :E2077-E2082
[10]   The Full Spectrum of Alzheimer's Disease Is Rooted in Metabolic Derangements That Drive Type 3 Diabetes [J].
de la Monte, Suzanne M. .
DIABETES MELLITUS: A RISK FACTOR FOR ALZHEIMER'S DISEASE, 2019, 1128 :45-83